Fans of wearable devices in more countries might start considering using the Samsung Galaxy Watch 3 or Watch Active 2 as their vital health monitoring features will be available soon. The tech company acquired the necessary permissions for its Health Monitor app to function in a total of 31 countries.
Samsung’s advanced health monitoring services cleared for use in more countries
The Samsung Galaxy Watch 3 and Watch Active 2 are equipped with sensors that allow them to monitor a user’s blood pressure and function with electrocardiogram (ECG) tracking. However, reading this data would require the Samsung Health Monitor app.
Like other health and medical products, the Samsung Health Monitor app needed to be approved in different countries following different regulations. It explains why tech features of this nature typically launch in limited territories. However, this changes for Samsung after the company acquired CE-marking last December for the software product allowing it to launch in European countries.
Samsung Galaxy Watch 3 and Watch Active 2 users Austria, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, the Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, and the United Kingdom will soon be able to use the said app for BP and ECG tracking. The app is also launching in Chile, Indonesia, and the UAE making it available in 31 countries after only being accessible in South Korea.
Once the Samsung Health Monitor app goes live in the said countries, Samsung Galaxy Watch 3 and Watch Active 2 have to be updated to their latest versions. Doing so will automatically install the app on the wearable devices. Updates can be initiated through the Galaxy Wearable app via a paired Galaxy smartphone.
Samsung Galaxy Watch 4 rumored to launch with blood sugar level sensor
Having a blood pressure and ECG monitor on people’s wrists through devices like Samsung Galaxy Watch 3 and Watch Active 2 is already a notable technological development. But the company is reportedly looking to add another essential medical tracker in its upcoming Galaxy Watch 4.
ET News reported that Samsung is planning to launch the Galaxy Watch 4 with blood sugar level tracking this year. It is expected to use optic sensors that would allow measure blood glucose levels without blood sampling.


SpaceX Reports $8 Billion Profit as IPO Plans and Starlink Growth Fuel Valuation Buzz
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SoftBank and Intel Partner to Develop Next-Generation Memory Chips for AI Data Centers
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Elon Musk’s Empire: SpaceX, Tesla, and xAI Merger Talks Spark Investor Debate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 



